baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Acuity Brands INC ACUITY BRANDS O.../ US00508Y1029 /

2021-08-23 12:00:00 AM	Chg. -	Volume	Bid6:00:05 AM	Ask6:00:05 AM	Market Capitalization	Dividend Y.	P/E Ratio
182.48USD	-	2 Turnover: -	-Bid Size: -	-Ask Size: -	7.99 bill.USD	0.20%	23.86

GlobeNewswire 05-15 Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

GlobeNewswire 05-15 Wondr Health and Solera Health Partner to Provide Expert Weight and Obesity-Management Solution for ...

GlobeNewswire 05-14 Parity Healthcare Analytics, Maine RMOMS Network launch program to support state’s obstetrical units

GlobeNewswire 05-14 Western University’s Faculty of Engineering Embraces Holistic Admissions with Acuity Insights’ Caspe...

GlobeNewswire 05-14 Newton Golf Shafts Helps Propel Doug Barron to His First Major Championship on the PGA TOUR Champion...

GlobeNewswire 05-14 Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-13 Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones

GlobeNewswire 05-10 Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update

GlobeNewswire 05-09 Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-09 AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion

GlobeNewswire 05-09 MeiraGTx Reports First Quarter 2024 Financial and Operational Results

GlobeNewswire 05-08 Oculis Reports Q1 2024 Financial Results and Provides Company Updates

GlobeNewswire 05-08 Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05 ...

GlobeNewswire 05-08 LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire 05-08 Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights

GlobeNewswire 05-07 Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Struc...

GlobeNewswire 05-07 EyeDNA Therapeutics Announces Positive 24-month Data Presented at ARVO from Ongoing Phase I/II Trial...

GlobeNewswire 05-06 Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...

GlobeNewswire 05-06 Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting

GlobeNewswire 05-06 AsclepiX Therapeutics Completes Enrollment in DISCOVER Trial for Neovascular Age-Related Macular Deg...

GlobeNewswire 05-06 Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular isch...

GlobeNewswire 05-03 Ocuphire Pharma to Present at the Aegis Virtual Conference

GlobeNewswire 05-01 WeightWatchers for Business and Personify Health Partner to Help Employers Address Weight Health Car...

GlobeNewswire 05-01 Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geog...

GlobeNewswire 05-01 Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evalu...

Acuity Brands INC ACUITY BRANDS O.../ US00508Y1029 /

If you wish to receive reply to your feedback, please provide your email address.